2016 International Congress Archives - Page 30 of 207

12:30pm-2:00pm: Longitudinal assessment of caregiver strain in Parkinson’s disease

C.K. Okoro, P. Schmidt, S.S. Wu, J.G. Goldman (Chicago, IL, USA)

Quality of life/caregiver burden in movement disorders · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Longitudinal assessment of sleep in an incident Parkinson’s disease cohort

S.T. O'Dowd, G.W. Duncan, T.K. Khoo, A.J. Yarnall, R.A. Lawson, D.J. Burn, K.N. Anderson (Newcastle upon Tyne, United Kingdom)

Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Longitudinal changes of speech and voice disorders following subthalamic stimulation in Parkinson’s disease patients

T. Tsuboi, H. Watanabe, Y. Tanaka, R. Ohdake, K. Kawabata, K. Hara, M. Ito, M. Hirayama, Y. Fujimoto, Y. Kajita, M. Katsuno, G. Sobue (Nagoya, Japan)

Surgical therapy: Parkinson's disease · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Longitudinal evolution of excessive daytime sleepiness in early Parkinson’s disease

T. Simuni, C. Caspell-Garcia, J. Long, C.S. Coffey, W. Oertel, S. Lasch, K. Marek, On behalf of the PPMI Sleep Working Group (Chicago, IL, USA)

Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Longitudinal evolution of possible REM sleep behavior disorder in early Parkinson’s disease

W. Oertel, T. Simuni, C. Caspell-Garcia, J. Long, C.S. Coffey, A. Iranzo, G. Mayer, L. Chahine, S. Lasch, K. Marek, On behalf of the PPMI Sleep Working Group (Marburg, Germany)

Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Loss of FBXO7 (PARK15) leads to disturbances in proteasomal function and models parkinsonism-like and pyramidal symptoms in mice

S. Vingill, D. Brockelt, N. Schwedhelm-Domeyer, L. Tatenhorst, S. Goebbels, P. Lingor, K.A. Nave, J. Stegmueller (Goettingen, Germany)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus) · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Low cerebrospinal fluid 3,4-dihydroxyphenylacetic acid and 3,4-dihydroxyphenylglycol levels are biomarkers of Parkinsonian disorders, including PSP

A. Stefani, C. Holmes, E. Olivola, Y. Sharabi, D. Goldstein (Rome, Italy)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus) · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: LRRK2, MAPT and HTRA2 mutations in the pedigree of familial neurodegenerative parkinsonism with cognitive deterioration spanning five generations in a genetically isolated population of south-eastern Moravia, Czech Republic

T. Bartonikova, R. Vodicka, K. Mensikova, R. Vrtel, P. Kanovsky, P. Otruba, M. Vastik, L. Mikulicova, S. Kurcova, P. Jugas, J. Ovecka, L. Sachova, F. Dvorsky (Olomouc, Czech Republic)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus) · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Magnetic resonance characteristic of Parkinson’s disease based on the presence of cognitive impairment

F.B. Doniyorova (Tashkent, Uzbekistan)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus) · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Magnetic resonance diffusion tensor imaging for the pedunculopontine nucleus: Correlation between neuroimaging and cytoarchitectonic features

A.T.D.L. Alho, C. Hamani, E.J.L. Alho, R.E. da Silva, G.A.B. dos Santos, R.C. Neves, C.M.M. Araujo, G. Magalhães, L.T. Grinberg, H. Heinsen, E.T. Fonoff, E. Amaro-Junior (São Paulo, Brazil)

Surgical therapy: Other movement disorders · Exhibit Hall located in Hall B, Level 2